Assignee
IMP CANCER RES TECH
GB·23 granted patents·5 pending applications·1,376 citations·filing 1988–2005
Top patents by PatentIndex Score
28 records- 0198US7173029B2Fused heteroaryl derivativesIMP CANCER RES TECH·Filed 2005·Granted Feb 6, 2007·93 cites·20 claims
- 0298US7037915B2Fused heteroaryl derivativesIMP CANCER RES TECH·Filed 2004·Granted May 2, 2006·93 cites·11 claims
- 0395US7060450B1Screening assays for agonists and antagonists of the hedgehog signaling pathwayIMP CANCER RES TECH·Filed 2000·Granted Jun 13, 2006·62 cites·29 claims
- 0493US6630148B1Compositions comprising hedgehog proteinsIMP CANCER RES TECH·Filed 1997·Granted Oct 7, 2003·55 cites·52 claims
- 0592US7118890B2Antibodies to vertebrate delta proteins and fragmentsIMP CANCER RES TECH·Filed 2001·Granted Oct 10, 2006·40 cites·67 claims
- 0691US6262025B1Nucleotide and protein sequences of vertebrate delta genes and methods based thereonIMP CANCER RES TECH·Filed 1996·Granted Jul 17, 2001·78 cites·59 claims
- 0791US6004924AProtein sequences of serrate gene productsIMP CANCER RES TECH·Filed 1996·Granted Dec 21, 1999·86 cites·75 claims
- 0890US6261786B1Screening assays for hedgehog agonists and antagonistsIMP CANCER RES TECH·Filed 1996·Granted Jul 17, 2001·67 cites·27 claims
- 0990US5885808AAdenovirus with modified binding moiety specific for the target cellsIMP CANCER RES TECH·Filed 1993·Granted Mar 23, 1999·294 cites·14 claims
- 1087US5869282ANucleotide and protein sequences of the serrate gene and methods based thereonIMP CANCER RES TECH·Filed 1995·Granted Feb 9, 1999·85 cites·109 claims
- 1183US5165923AMethods and compositions for the treatment of hodgkin's diseaseIMP CANCER RES TECH·Filed 1989·Granted Nov 24, 1992·76 cites·29 claims
- 1276US6268129B1Method of nucleic acid analysisIMP CANCER RES TECH·Filed 1996·Granted Jul 31, 2001·82 cites·44 claims
- 1376US6054438ANucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucinIMP CANCER RES TECH·Filed 1995·Granted Apr 25, 2000·53 cites·28 claims
- 1473US5683674AAntibody against human mucin core protein and method of preparing and using sameIMP CANCER RES TECH·Filed 1995·Granted Nov 4, 1997·43 cites·18 claims
- 1568US5965710AMonoclonal antibodies for use in diagnosis and treatment of colorectal cancerIMP CANCER RES TECH·Filed 1994·Granted Oct 12, 1999·38 cites·1 claims
- 1666US6222020B1Antigens derived from the core protein of the human mammary epithelial mucinIMP CANCER RES TECH·Filed 1995·Granted Apr 24, 2001·28 cites·32 claims
- 1759US5981174AGenetic assayIMP CANCER RES TECH·Filed 1993·Granted Nov 9, 1999·35 cites·16 claims
- 1858US5973116ACompounds for targetingIMP CANCER RES TECH·Filed 1994·Granted Oct 26, 1999·23 cites·10 claims
- 1955US5098823AChromosome-specific nucleic acid probe for familial polyposis coliIMP CANCER RES TECH·Filed 1988·Granted Mar 24, 1992·21 cites·21 claims
- 2052US2004224882A1Vertebrate embryonic pattern inducing proteins and uses related theretoIMP CANCER RES TECH·Filed 2003·Application pending·0 cites
- 2150US2003211521A1Breast cancer antigenIMP CANCER RES TECH·Filed 2003·Application pending·0 cites
- 2246US6287854B1Diagnosis of susceptibility to cancer and treatment thereofIMP CANCER RES TECH·Filed 1997·Granted Sep 11, 2001·13 cites·30 claims
- 2346US2005142640A1MUC-1 derived peptidesIMP CANCER RES TECH·Filed 2005·Application pending·0 cites
- 2445US2002114813A1CompoundsIMP CANCER RES TECH·Filed 2001·Application pending·0 cites
- 2534US2009013417A1Transgenic Animals for Assessing Drug Metabolism and Toxicity in ManIMP CANCER RES TECH·Filed 2005·Application pending·0 cites
- 2626US6187993B1Transgenic animals as model of psoriasisIMP CANCER RES TECH·Filed 1996·Granted Feb 13, 2001·4 cites·14 claims
- 2726US5441935AGrowth factor receptorsIMP CANCER RES TECH·Filed 1992·Granted Aug 15, 1995·2 cites·3 claims
- 2826US5434132ANeuropeptide antagonistsIMP CANCER RES TECH·Filed 1993·Granted Jul 18, 1995·5 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when IMP CANCER RES TECH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →